Showing results (881-890 of 3,241) with videos related to
Sort By:
Pageof 325
Journal of Clinical Pharmacy and Therapeutics|December 20, 2019
Immunosuppressives and enteral feeding tubes: An integrative reviewRenan M E Silva, Rosana D P Portela, Iwyson H F da Costa, et al.Journal of Clinical Pharmacy and Therapeutics|November 23, 2019
Clinically significant drug-drug interaction between tacrolimus and fluconazole in stable renal transplant recipient and literature reviewJiake He, Yang Yu, Chenglong Yin, et al.Journal of Clinical Pharmacy and Therapeutics|November 26, 2019
Successful use of once-daily high-dose darunavir and dolutegravir in multidrug-resistant HIVPatricia P Fulco, Crystal R Leibrand Kaczmar, Denese Gomes, et al.Journal of Clinical Pharmacy and Therapeutics|December 6, 2019
Target-controlled infusion of dexmedetomidine effect-site concentration for sedation in patients undergoing spinal anaesthesiaKyung Mi Kim, Kwon Hui Seo, Jung Min Lee, et al.Journal of Clinical Pharmacy and Therapeutics|February 19, 2020
Recent advances in targeted small-molecule inhibitor therapy for non-small-cell lung cancer-An updateShubham Atal, Pravin Asokan, Ratinder JhajJournal of Clinical Pharmacy and Therapeutics|June 1, 1988
Bioavailability and acceptability of a dispersible formulation of levodopa-benserazide in parkinsonian patients with and without dysphagiaA J Bayer, J J Day, P Finucane, et al.Journal of Clinical Pharmacy and Therapeutics|June 1, 1988
Colorimetric determination of tobramycin in parenteral solutionsV Das GuptaJournal of Clinical Pharmacy and Therapeutics|February 14, 2020
Quality of phase I clinical drug trials: Influence of organizational management factorsYang Zhao, Qiuxia Yang, Xinping ZhangJournal of Clinical Pharmacy and Therapeutics|January 18, 2020
The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: A systematic review and meta-analysisHui Yang, Lizhen Pang, Xiaopeng Hu, et al.Journal of Clinical Pharmacy and Therapeutics|December 18, 2019
Post-marketing safety-related regulatory actions on first-in-class drugs: A double-cohort studyJunji Ikeda, Masayuki Kaneko, Mamoru NarukawaPageof 325